Factor IX binding to collagen [PDF]
At a site of vascular injury, numerous cellular and protein constituents of blood bind to components of extracellular matrices in the vessel wall. These interactions are critical for normal clot formation. In this issue of the Journal of Thrombosis and Haemostasis, Gui et al.
openaire +2 more sources
253. Encapsulated Primary Myoblasts Deliver Sustained and Therapeutic Levels of Human Factor IX to Hemophilic Mice [PDF]
openalex +1 more source
ABSTRACT Background Neurodegeneration with brain iron accumulation (NBIA) comprises a genetically and clinically heterogeneous group of rare neurological disorders characterized particularly by iron accumulation in the basal ganglia. To date, 15 genes have been associated with NBIA.
Seda Susgun +95 more
wiley +1 more source
Simplifying surgery in haemophilia B: Low factor IX consumption and infrequent infusions in surgical procedures with rIX-FP [PDF]
Julie Curtin +5 more
openalex +1 more source
Clinical Characteristics and Outcomes of Early‐Onset Versus Late‐Onset LGI1‐Antibody Encephalitis
ABSTRACT Background Leucine‐rich glioma‐inactivated 1 antibody (LGI1‐Ab) encephalitis predominantly affected older individuals, but has also been reported in younger patients. However, the demographic, clinical, and prognostic characteristics of early‐onset LGI1‐Ab encephalitis have yet to be systematically elucidated. This study aims to systematically
Yu Kong +7 more
wiley +1 more source
251. Creation and Characterization of High Titer AAV-Factor IX Producing Clones for Clinical Scale Production [PDF]
openalex +1 more source
Portable Low‐Field Magnetic Resonance Imaging in People With Human Immunodeficiency Virus
ABSTRACT Objective The aging population of people with HIV (PWH) raises heightened concerns regarding accelerated aging and dementia. Portable, low‐field MRI (LF‐MRI) is an innovative technology that could enhance access and facilitate routine monitoring of PWH.
Annabel Sorby‐Adams +14 more
wiley +1 more source
THE USE OF EMICIZUMAB IN A CHILD WITH HEMOPHILIA A INHIBITORY FOREMA
Hemophilia is a disease caused by hereditary deficiency of plasma coagulation factors VIII (FVIII) (hemophilia A) or IX (FIX) (hemophilia B) and characterized by hematomic bleeding.
Юлия Олеговна Рождественская +9 more
doaj
Circulating Factor IX Antigen-Inhibitor Complexes in Hemophilia B- Following Infusion of a Factor IX Concentrate [PDF]
Scott H. Goodnight +3 more
openalex +1 more source
Supplementary Figure 1-6 from A Novel Tumor-Promoting Role for Nuclear Factor IX in Glioblastoma Is Mediated through Transcriptional Activation of GINS1 [PDF]
Ruixiang Ge +5 more
openalex +1 more source

